We came across a bullish thesis on Kenvue Inc. on The Value Road’s Substack. In this article, we will summarize the bulls’ thesis on KVUE which was published before KVUE's acquisition announcement. Kenvue Inc.'s share was trading at $17.35 as of November 28th. KVUE’s trailing and forward P/E were 23.13 and 15.77 respectively according to Yahoo Finance.
[caption id="attachment_565118" align="aligncenter" width="750"]Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific,...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.